$EVEX
Eve Holding, Inc. Stock $evex

$evex Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000155485524000334 Filed on May 07, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.400M	$6.477M	$6.154M
YoY Change	-18.59%	5.24%	660.95%
% of Gross Profit
Research & Development	$36.32M	$27.46M	$21.53M
YoY Change	66.43%	27.53%	136.19%
% of Gross Profit
Depreciation & Amortization	$58.00K	$51.00K	$22.05K
YoY Change	-28.47%	131.29%
% of Gross Profit
Operating Expenses	$41.72M	$33.93M	$27.68M
YoY Change	46.61%	22.57%	178.96%
Operating Profit	-$41.72M	-$33.93M	-$27.68M
YoY Change	46.61%	22.57%	165.34%
Interest Expense	$613.0K	$412.0K	$2.084M
YoY Change	-123.11%	-80.23%	368.48%
% of Operating Profit
Other Income/Expense, Net	$1.053M	-$229.0K	$34.00K
YoY Change	611.49%	-773.53%	-253.02%
Pretax Income	-$35.99M	-$24.67M	-$25.60M
YoY Change	15.71%	-3.61%	169.43%
Income Tax	$395.0K	$600.0K	$173.7K
% Of Pretax Income
Net Earnings	-$36.39M	-$25.30M	-$25.77M
YoY Change	15.85%	-1.85%	171.26%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.13	-$0.09	-$0.09
Diluted Earnings Per Share	-$0.13	-$0.09	-$0.09
COMMON SHARES
Basic Shares Outstanding	269.4M shares	269.4M shares	269.1M shares
Diluted Shares Outstanding	276.4M shares	276.3M shares	275.5M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$121.0M	$138.3M	$211.0M
YoY Change	-34.37%	-34.44%	854668.4%
Cash & Equivalents	$27.76M	$23.59M	$11.84M
Short-Term Investments	$93.23M	$114.7M	$199.1M
Other Short-Term Assets	$3.875M	$1.601M	$740.7K
YoY Change	165.06%	116.15%	772.44%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$210.4M	$224.3M	$295.5M
YoY Change	-22.32%	-24.12%	269599.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.235M	$514.0K	$594.3K
YoY Change	140.35%	-13.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$212.0K	$811.0K
YoY Change
Total Long-Term Assets	$4.198M	$4.058M	$801.5K
YoY Change	294.56%	406.33%	-99.66%
TOTAL ASSETS
Total Short-Term Assets	$210.4M	$224.3M	$295.5M
Total Long-Term Assets	$4.198M	$4.058M	$801.5K
Total Assets	$214.6M	$228.3M	$296.3M
YoY Change	-21.08%	-22.95%	25.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.822M	$1.648M	$490.1K
YoY Change	20.06%	236.22%	-91.41%
Accrued Expenses	$19.11M	$12.91M	$5.046M
YoY Change	729.56%	155.87%	418.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$54.33M	$45.21M	$32.86M
YoY Change	40.81%	37.57%	460.89%
LONG-TERM LIABILITIES
Long-Term Debt	$52.60M	$40.04M	$0.00
YoY Change
Other Long-Term Liabilities	$2.528M	$2.191M	$976.3K
YoY Change	65.17%	124.42%	-96.04%
Total Long-Term Liabilities	$55.13M	$42.23M	$976.3K
YoY Change	3502.17%	4225.71%	-96.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$54.33M	$45.21M	$32.86M
Total Long-Term Liabilities	$55.13M	$42.23M	$976.3K
Total Liabilities	$109.5M	$87.44M	$33.84M
YoY Change	172.86%	158.41%	10.84%
SHAREHOLDERS EQUITY
Retained Earnings	-$406.4M	-$370.0M	-$242.8M
YoY Change	48.2%	52.39%
Common Stock	$511.4M	$510.8M	$505.3M
YoY Change	1.09%	1.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$105.1M	$140.9M	$262.5M
YoY Change
Total Liabilities & Shareholders Equity	$214.6M	$228.3M	$296.3M
YoY Change	-21.08%	-22.95%	25.01%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$36.39M	-$25.30M	-$25.77M
YoY Change	15.85%	-1.85%	171.26%
Depreciation, Depletion And Amortization	$58.00K	$51.00K	$22.05K
YoY Change	-28.47%	131.29%
Cash From Operating Activities	-$30.75M	-$35.81M	-$19.89M
YoY Change	10.98%	80.05%	3211.54%
INVESTING ACTIVITIES
Capital Expenditures	$659.0K	$106.0K	$43.70K
YoY Change	441.58%	142.57%
Acquisitions
YoY Change
Other Investing Activities	$22.00M	-$2.000M	-$17.50M
YoY Change	-55.56%	-88.57%
Cash From Investing Activities	$21.34M	-$2.106M	-$17.54M
YoY Change	-56.78%	-88.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	14.25M	$14.75M	$0.00
YoY Change	-5061.17%		-100.0%
NET CHANGE
Cash From Operating Activities	-30.75M	-$35.81M	-$19.89M
Cash From Investing Activities	21.34M	-$2.106M	-$17.54M
Cash From Financing Activities	14.25M	$14.75M	$0.00
Net Change In Cash	4.832M	-$23.29M	-$37.31M
YoY Change	-77.4%	-37.56%	8178.72%
FREE CASH FLOW
Cash From Operating Activities	-$30.75M	-$35.81M	-$19.89M
Capital Expenditures	$659.0K	$106.0K	$43.70K
Free Cash Flow	-$31.41M	-$35.92M	-$19.93M
YoY Change	12.86%	80.18%	3218.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46882000	usd
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#DerivativeLiabilitiesCurrent
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001823652
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2024Q1	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#DerivativeLiabilitiesCurrent
CY2024Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-39704
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	EVE HOLDING, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2549808
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1400 General Aviation Drive
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Melbourne
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32935
CY2024Q1	dei	City Area Code CityAreaCode	(321)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	751-5050
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	269365708	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23588000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46882000	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	114714000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	111218000	usd
CY2024Q1	evex	Loans Receivable Related Parties Current LoansReceivableRelatedPartiesCurrent	84264000	usd
CY2023Q4	evex	Loans Receivable Related Parties Current LoansReceivableRelatedPartiesCurrent	83042000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1601000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	889000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	224267000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	242221000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	514000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	547000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1019000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	508000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1714000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1714000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	811000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	348000	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	4058000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3118000	usd
CY2024Q1	us-gaap	Assets Assets	228325000	usd
CY2023Q4	us-gaap	Assets Assets	245339000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1648000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4571000	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	7624000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13965000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	45212000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	51989000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	40041000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25764000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	42232000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	28299000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	87444000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	80288000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	269000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	269000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	510574000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	509448000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-369963000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-344667000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	140881000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	165051000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	228325000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	245339000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27455000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21528000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6477000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6154000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-33932000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-27683000	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	6341000	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-2195000	usd
CY2024Q1	us-gaap	Investment Income Net InvestmentIncomeNet	2337000	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	3254000	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1222000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	990000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	412000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	0	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-229000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	34000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24673000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25598000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	623000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	174000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-25296000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25772000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	276263000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	276263000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	275494000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275494000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-25296000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25772000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25296000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25772000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	286922000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25772000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	868000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	480000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	262498000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	165051000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-25296000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1126000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	140881000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-25296000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25772000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	51000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22000	usd
CY2024Q1	evex	Noncash Lease Expenses Amortization And Interest NoncashLeaseExpensesAmortizationAndInterest	54000	usd
CY2023Q1	evex	Noncash Lease Expenses Amortization And Interest NoncashLeaseExpensesAmortizationAndInterest	9000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	315000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	59000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1126000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	868000	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	480000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	6341000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-2195000	usd
CY2024Q1	evex	Interest Income On Financial Investments InterestIncomeOnFinancialInvestments	1497000	usd
CY2023Q1	evex	Interest Income On Financial Investments InterestIncomeOnFinancialInvestments	2838000	usd
CY2024Q1	evex	Interest Income On Related Party Loan Receivable InterestIncomeOnRelatedPartyLoanReceivable	1222000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1285000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-716000	usd
CY2024Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-206000	usd
CY2023Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-104000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2909000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1708000	usd
CY2024Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	1319000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	3588000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	296000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3495000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35813000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19891000	usd
CY2024Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	10000000	usd
CY2023Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	12000000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	17500000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	106000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2106000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17544000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	14966000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	219000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14747000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-122000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	126000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-23294000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-37309000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46882000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49146000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23588000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11837000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	949000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	148000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	273000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	121000	usd
CY2024Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	564000	usd
CY2023Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	41000	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin: 0pt 0pt 10pt; color: #000000; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0pt; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'Times New Roman'; line-height: 1.2; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-weight: bold; line-height: inherit;">Use of Estimates</span></p> <p style="margin: 0px; color: #000000; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'Times New Roman'; text-align: justify; line-height: 1.2;"><span style="font-size: 10pt; font-family: 'Times New Roman', serif; line-height: inherit;"><span style="line-height: inherit;">The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires the Company’s management to make estimates and judgments that affected the reported amounts of assets and liabilities and allocations of expenses. These judgments were based on the historical experience, management’s evaluation of trends in the industry and other factors that were deemed relevant at that time. The estimates and assumptions were reviewed on a regular basis and the changes to accounting estimates were recognized in the period in which the estimates were revised. The Company’s management recognizes that the actual results could be materially different from the estimates.<span> </span></span></span></p>
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="margin: 0px; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 15.6933px; font-size: 11pt; font-family: Calibri, sans-serif;"><b><span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif;">Prior Period Reclassification</span></b></p> <p style="margin: 0pt; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'Times New Roman'; font-size: 13.3333px; text-align: justify; line-height: 1.2;"><br/></p> <p style="margin: 0pt; color: #000000; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0pt; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.2; font-family: Calibri, sans-serif; text-align: justify;"><span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif;">We have reclassified certain prior period amounts to conform to the current period presentation. These reclassifications had no effect on the reported results of operations.</span></p>
CY2024Q1	us-gaap	Cash Cash	8096000	usd
CY2023Q4	us-gaap	Cash Cash	9173000	usd
CY2024Q1	evex	Private Securities At Carrying Value PrivateSecuritiesAtCarryingValue	5455000	usd
CY2023Q4	evex	Private Securities At Carrying Value PrivateSecuritiesAtCarryingValue	4385000	usd
CY2024Q1	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	10038000	usd
CY2023Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	33325000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23588000	usd
CY2024Q1	us-gaap	Maturity Of Time Deposits MaturityOfTimeDeposits	P90D
CY2023Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	0	usd
CY2024Q1	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	0	usd
CY2024Q1	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	21639000	usd
CY2023Q1	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	15743000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	715000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	707000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	202000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	160000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	514000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	547000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	40616000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	26069000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	575000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	305000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	40041000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	25764000	usd
CY2024Q1	evex	Deferred Charges Related To Debt Issuance Costs DeferredChargesRelatedToDebtIssuanceCosts	288000	usd
CY2023Q4	evex	Deferred Charges Related To Debt Issuance Costs DeferredChargesRelatedToDebtIssuanceCosts	348000	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	7600000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	14000000	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	6300000	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-2200000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	269365708	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	269365708	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	269359021	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	269359021	shares
CY2024Q1	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one vote per share
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-25296000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25772000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	276263000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	276263000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	275494000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275494000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	57413000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	57837000	shares
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	600000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1019000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	508000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1011000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	510000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	344000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	459000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	221000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	92000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1116000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	105000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1011000	usd
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	number
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	number
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27455000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21528000	usd
CY2024Q1	evex	Other Operating And Nonoperating Income Expense Net OtherOperatingAndNonoperatingIncomeExpenseNet	-2782000	usd
CY2023Q1	evex	Other Operating And Nonoperating Income Expense Net OtherOperatingAndNonoperatingIncomeExpenseNet	4070000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24673000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25598000	usd

Files In Submission

Name	View Source	Status
0001554855-24-000334-index-headers.html	Edgar Link	pending
0001554855-24-000334-index.html	Edgar Link	pending
0001554855-24-000334.txt	Edgar Link	pending
0001554855-24-000334-xbrl.zip	Edgar Link	pending
evex-20240331.htm	Edgar Link	pending
evex-20240331.xsd	Edgar Link	pending
evex-20240331_cal.xml	Edgar Link	unprocessable
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
ex322_4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
evex-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
evex-20240331_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
evex-20240331_def.xml	Edgar Link	unprocessable
evex-20240331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EVEX
Eve Holding, Inc. Stock $evex

2024 Q2 Form 10-Q Financial Statement

#000155485524000334 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVEX Eve Holding, Inc. Stock $evex

2024 Q2 Form 10-Q Financial Statement

#000155485524000334 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVEX
Eve Holding, Inc. Stock $evex